Northern Trust’s Allergan plc AGN.PRA Stock Holding History

Northern Trust’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-288	Closed	-$220K	–	4291
2016 Q4	$220K	Buy	+288	New	+$218K	﹤0.01%	3734

Other funds holding AGN.PRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Northern Trust's AGN.PRA Position: Q1 2017 in Review

Northern Trust sold out of Allergan plc (AGN.PRA) in Q1 2017, closing a stake of 288 shares — an estimated $220K sold.

Northern Trust first reported a position in AGN.PRA in Q4 2016 and held it in 1 quarter. The position peaked at $220K in Q4 2016. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2017.

Northern Trust reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
Northern Trust sold 288 Allergan plc shares in Q1 2017, an estimated $220K.
Northern Trust first reported a position in Allergan plc in Q4 2016 and held it in 1 quarter.
Northern Trust's Allergan plc position peaked at $220K in Q4 2016.
106 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Northern Trust's 13F filing for Q1 2017, filed 12 May 2017.